HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,007,203 | +57.8% | 357,303 | +50.0% | 0.04% | +68.2% |
| Q2 2023 | $20,282,987 | +1.6% | 238,231 | -1.2% | 0.02% | 0.0% |
| Q1 2023 | $19,959,383 | +3.3% | 241,201 | -1.8% | 0.02% | 0.0% |
| Q4 2022 | $19,318,642 | -13.4% | 245,628 | -18.5% | 0.02% | -15.4% |
| Q3 2022 | $22,303,000 | -9.3% | 301,275 | -20.1% | 0.03% | -7.1% |
| Q2 2022 | $24,589,000 | +913.6% | 377,252 | +808.7% | 0.03% | +1300.0% |
| Q1 2022 | $2,426,000 | +591.2% | 41,516 | +527.3% | 0.00% | – |
| Q4 2021 | $351,000 | -23.5% | 6,618 | +1.7% | 0.00% | – |
| Q3 2021 | $459,000 | +7.2% | 6,507 | +1.3% | 0.00% | – |
| Q2 2021 | $428,000 | -42.3% | 6,424 | -3.9% | 0.00% | -100.0% |
| Q1 2021 | $742,000 | -10.4% | 6,688 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $828,000 | -73.0% | 6,975 | -80.2% | 0.00% | -75.0% |
| Q3 2020 | $3,067,000 | -3.8% | 35,154 | -1.2% | 0.00% | 0.0% |
| Q2 2020 | $3,187,000 | -48.9% | 35,586 | -43.2% | 0.00% | -20.0% |
| Q1 2020 | $6,240,000 | +333.6% | 62,616 | +399.8% | 0.01% | +150.0% |
| Q4 2019 | $1,439,000 | +24.3% | 12,528 | +36.5% | 0.00% | +100.0% |
| Q3 2019 | $1,158,000 | -96.0% | 9,177 | -97.1% | 0.00% | -98.4% |
| Q2 2018 | $28,666,000 | -74.0% | 319,653 | -78.8% | 0.06% | -74.7% |
| Q1 2018 | $110,318,000 | -21.8% | 1,507,894 | -37.9% | 0.24% | -18.9% |
| Q4 2017 | $141,032,000 | +30.2% | 2,428,236 | +0.6% | 0.30% | +22.2% |
| Q3 2017 | $108,340,000 | +34.9% | 2,414,526 | +18.7% | 0.24% | +29.3% |
| Q2 2017 | $80,303,000 | -17.3% | 2,033,514 | -15.1% | 0.19% | -18.6% |
| Q1 2017 | $97,130,000 | +12.0% | 2,394,135 | +11.0% | 0.23% | +5.5% |
| Q4 2016 | $86,738,000 | +22.0% | 2,157,654 | +9.9% | 0.22% | +10.1% |
| Q3 2016 | $71,105,000 | +67.3% | 1,963,684 | +34.0% | 0.20% | +17.1% |
| Q2 2016 | $42,495,000 | -9.9% | 1,465,850 | +8.7% | 0.17% | -12.8% |
| Q1 2016 | $47,157,000 | +10.5% | 1,348,125 | +1.9% | 0.20% | +10.2% |
| Q4 2015 | $42,667,000 | +16.8% | 1,323,400 | +17.1% | 0.18% | +18.0% |
| Q3 2015 | $36,516,000 | +10.9% | 1,129,850 | +42.0% | 0.15% | +23.0% |
| Q2 2015 | $32,919,000 | -8.4% | 795,900 | -0.6% | 0.12% | -5.4% |
| Q1 2015 | $35,954,000 | +78.5% | 800,400 | +48.7% | 0.13% | +74.3% |
| Q4 2014 | $20,141,000 | – | 538,250 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |